KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Chemed (CHE) over the last 17 years, with Q2 2025 value amounting to $2.2 million.

  • Chemed's Gains from Investment Securities rose 84893.62% to $2.2 million in Q2 2025 from the same period last year, while for Sep 2025 it was $9.1 million, marking a year-over-year decrease of 2955.63%. This contributed to the annual value of $9.5 million for FY2024, which is 104.64% down from last year.
  • According to the latest figures from Q2 2025, Chemed's Gains from Investment Securities is $2.2 million, which was up 84893.62% from $6.3 million recorded in Q1 2025.
  • In the past 5 years, Chemed's Gains from Investment Securities registered a high of $7.2 million during Q2 2022, and its lowest value of $133000.0 during Q3 2023.
  • Its 5-year average for Gains from Investment Securities is $3.2 million, with a median of $3.0 million in 2022.
  • The largest annual percentage gain for Chemed's Gains from Investment Securities in the last 5 years was 205563.91% (2024), contrasted with its biggest fall of 8905.45% (2024).
  • Chemed's Gains from Investment Securities (Quarter) stood at $5.7 million in 2021, then tumbled by 45.21% to $3.1 million in 2022, then surged by 32.02% to $4.1 million in 2023, then plummeted by 84.68% to $630000.0 in 2024, then surged by 253.97% to $2.2 million in 2025.
  • Its last three reported values are $2.2 million in Q2 2025, $6.3 million for Q1 2025, and $630000.0 during Q4 2024.